These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 14984924)

  • 1. The metabolic syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm.
    Olijhoek JK; van der Graaf Y; Banga JD; Algra A; Rabelink TJ; Visseren FL;
    Eur Heart J; 2004 Feb; 25(4):342-8. PubMed ID: 14984924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm.
    Gorter PM; Olijhoek JK; van der Graaf Y; Algra A; Rabelink TJ; Visseren FL;
    Atherosclerosis; 2004 Apr; 173(2):363-9. PubMed ID: 15064114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abdominal fat and risk of coronary heart disease in patients with peripheral arterial disease.
    Brouwer BG; Visseren FL; Stolk RP; van der Graaf Y;
    Obesity (Silver Spring); 2007 Jun; 15(6):1623-30. PubMed ID: 17558001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of drinking pattern and alcohol beverage type with the prevalence of metabolic syndrome, diabetes, coronary heart disease, stroke, and peripheral arterial disease in a Mediterranean cohort.
    Athyros VG; Liberopoulos EN; Mikhailidis DP; Papageorgiou AA; Ganotakis ES; Tziomalos K; Kakafika AI; Karagiannis A; Lambropoulos S; Elisaf M
    Angiology; 2007 Dec-2008 Jan; 58(6):689-97. PubMed ID: 18216378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum uric acid levels and risk for vascular diseases in patients with metabolic syndrome.
    Hjortnaes J; Algra A; Olijhoek J; Huisman M; Jacobs J; van der Graaf Y; Visseren F
    J Rheumatol; 2007 Sep; 34(9):1882-7. PubMed ID: 17696269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of parental coronary artery disease on adverse effects of the metabolic syndrome and aging on carotid artery intima-media thickness (from the Bogalusa Heart Study).
    Chen W; Srinivasan SR; Xu J; Berenson GS
    Am J Cardiol; 2008 Jul; 102(2):180-3. PubMed ID: 18602517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the new International Diabetes Federation definition of metabolic syndrome improve prediction of coronary artery disease and carotid intima-media thickening?
    Timóteo A; Santos R; Lima S; Mamede A; Fernandes R; Ferreira R
    Rev Port Cardiol; 2009 Feb; 28(2):173-81. PubMed ID: 19438152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome and the risk of new vascular events and all-cause mortality in patients with coronary artery disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm.
    Wassink AM; van der Graaf Y; Olijhoek JK; Visseren FL;
    Eur Heart J; 2008 Jan; 29(2):213-23. PubMed ID: 18199567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of metabolic syndrome or type II diabetes mellitus on the occurrence of recurrent vascular events in hypertensive patients.
    Vlek AL; van der Graaf Y; Spiering W; Visseren FL;
    J Hum Hypertens; 2008 May; 22(5):358-65. PubMed ID: 18273039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome and C-reactive protein among cardiology patients.
    Chapidze G; Dolidze N; Enquobahrie DA; Kapanadze S; Latsabidze N; Williams MA
    Arch Med Res; 2007 Oct; 38(7):783-8. PubMed ID: 17845899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of C-reactive protein on the likelihood of peripheral arterial disease in United States adults with the metabolic syndrome, diabetes mellitus, and preexisting cardiovascular disease.
    Vu JD; Vu JB; Pio JR; Malik S; Franklin SS; Chen RS; Wong ND
    Am J Cardiol; 2005 Sep; 96(5):655-8. PubMed ID: 16125489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BMI versus the metabolic syndrome in relation to cardiovascular risk in elderly Chinese individuals.
    He Y; Jiang B; Wang J; Feng K; Chang Q; Zhu S; Fan L; Li X; Hu FB
    Diabetes Care; 2007 Aug; 30(8):2128-34. PubMed ID: 17468350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metabolic syndrome in type 2 diabetes: When does it matter?
    Wong J; Molyneaux L; Constantino MI; Twigg SM; Yue DK
    Diabetes Obes Metab; 2006 Nov; 8(6):690-7. PubMed ID: 17026494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral arterial disease in patients with stages IV and V chronic renal failure.
    Guerrero A; Montes R; Muñoz-Terol J; Gil-Peralta A; Toro J; Naranjo M; González-Pérez P; Martín-Herrera C; Ruiz-Fernández A
    Nephrol Dial Transplant; 2006 Dec; 21(12):3525-31. PubMed ID: 16940320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between peripheral arterial disease and metabolic syndrome.
    Maksimovic M; Vlajinac H; Radak D; Marinkovic J; Jorga J
    Angiology; 2009; 60(5):546-53. PubMed ID: 19147526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study.
    Mattace-Raso FU; van der Cammen TJ; Hofman A; van Popele NM; Bos ML; Schalekamp MA; Asmar R; Reneman RS; Hoeks AP; Breteler MM; Witteman JC
    Circulation; 2006 Feb; 113(5):657-63. PubMed ID: 16461838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of peripheral arterial disease and prior stroke in octogenarians with symptomatic severe aortic stenosis or severe coronary artery disease: influence in management and outcome.
    Martinez-Selles M; Barrio JM; Hortal J; Ruiz M; Bueno H
    Int Angiol; 2007 Mar; 26(1):33-7. PubMed ID: 17353886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes.
    Tong PC; Kong AP; So WY; Yang X; Ho CS; Ma RC; Ozaki R; Chow CC; Lam CW; Chan JC; Cockram CS
    Diabetes Care; 2007 May; 30(5):1206-11. PubMed ID: 17259472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular risk factor management is poorer in diabetic patients with undiagnosed peripheral arterial disease than in those with known coronary heart disease or cerebrovascular disease. Results of a nationwide study in tertiary diabetes centres.
    González-Clemente JM; Piniés JA; Calle-Pascual A; Saavedra A; Sánchez C; Bellido D; Martín-Folgueras T; Moraga I; Recasens A; Girbés J; Sánchez-Zamorano MA; Mauricio D;
    Diabet Med; 2008 Apr; 25(4):427-34. PubMed ID: 18341592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased prevalence of cardiovascular disease in Type 2 diabetic patients with non-alcoholic fatty liver disease.
    Targher G; Bertolini L; Padovani R; Poli F; Scala L; Tessari R; Zenari L; Falezza G
    Diabet Med; 2006 Apr; 23(4):403-9. PubMed ID: 16620269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.